CM
HAE icon

Castleark Management’s Haemonetics HAE Stock Holding History

Castleark Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,300
Closed -$3.87M – 316
2025
Q4 		$3.87M Buy
+48,300
New +$3.25M 0.11% 170
2024
Q1 		– Sell
-46,380
Closed -$3.97M – 295
2023
Q4 		$3.97M Buy
+46,380
New +$4.01M 0.18% 138
2023
Q3 		– Sell
-12,610
Closed -$1.07M – 294
2023
Q2 		$1.07M Sell
12,610
-53,870
-81% -$4.55M 0.05% 186
2023
Q1 		$5.5M Sell
66,480
-29,950
-31% -$2.42M 0.27% 86
2022
Q4 		$7.58M Sell
96,430
-5,910
-6% -$475K 0.4% 57
2022
Q3 		$7.58M Buy
102,340
+19,290
+23% +$1.39M 0.42% 49
2022
Q2 		$5.41M Buy
+83,050
New +$4.92M 0.29% 84
2020
Q1 		– Sell
-82,292
Closed -$9.46M – 354
2019
Q4 		$9.46M Sell
82,292
-32,558
-28% -$3.94M 0.38% 84
2019
Q3 		$14.5M Buy
114,850
+110
+0.1% +$14K 0.59% 39
2019
Q2 		$13.8M Buy
+114,740
New +$11.3M 0.53% 42
2019
Q1 		– Sell
-113,412
Closed -$11.3M – 377
2018
Q4 		$11.3M Sell
113,412
-48,810
-30% -$5.13M 0.48% 54
2018
Q3 		$18.6M Sell
162,222
-64,380
-28% -$6.66M 0.53% 44
2018
Q2 		$20.3M Sell
226,602
-7,754
-3% -$655K 0.63% 36
2018
Q1 		$17.1M Buy
234,356
+52,861
+29% +$3.63M 0.54% 43
2017
Q4 		$10.5M Buy
+181,495
New +$9.56M 0.32% 110

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Castleark Management's HAE Position: Q1 2026 in Review

Castleark Management sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 48,300 shares — an estimated $3.87M sold.

Castleark Management first reported a position in HAE in Q4 2017 and held it in 15 quarters. The position peaked at $20.3M in Q2 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Castleark Management reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Castleark Management sold 48,300 Haemonetics shares in Q1 2026, an estimated $3.87M.
  • Castleark Management first reported a position in Haemonetics in Q4 2017 and held it in 15 quarters.
  • Castleark Management's Haemonetics position peaked at $20.3M in Q2 2018.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Castleark Management's 13F filing for Q1 2026, filed 15 May 2026.